Greg Katz's Newsletter

Greg Katz's Newsletter

Home
Notes
Archive
About

July 2025

The MAHA Wishlist: Let's Find Out What Actually Works
The news that Coke is going to offer soda with real cane sugar instead of high fructose corn syrup raises the question of whether the MAHA agenda is…
 • 
Gregory Katz, MD
Everyone Takes Vitamin D. No One Knows Why.
Vitamin D seems to have near-universal approval.
 • 
Gregory Katz, MD
1
All research should have an expiration date
Reflections on the REDUCE-AMI trial and why beta blockers after a heart attack might not be necessary for all patients
 • 
Gregory Katz, MD
32:12
The Most Ambitious Idea in Cardiology Right Now: Gene Editing for Heart Disease
The news that Eli Lilly is acquiring Verve Therapeutics is fascinating. They’re dropping around $1.3 billion to buy a company that is pioneering a…
 • 
Gregory Katz, MD

June 2025

What the Hell is Metabolic Health?
Metabolic health is having a moment.
 • 
Gregory Katz, MD
Exercise Might Be a Cancer Drug. Sort Of.
A new study in the New England Journal of Medicine made waves with an almost unbelievable result: a structured exercise program for colon cancer…
 • 
Gregory Katz, MD
Advice for new doctors - how to start strong in residency
The end of June and beginning of July marks the start of a new medical year—when freshly minted interns take their first steps as doctors, and new roles…
 • 
Gregory Katz, MD
1
Everyone Has an Opinion on Statins (and Almost None of It Is Useful)
Over the past week, I had 4 different patients come to see me after a heart attack or stroke who were terrified about being on a statin.
 • 
Gregory Katz, MD

May 2025

© 2025 Gregory Katz
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture